AU1198601A - Composition and method for stable injectable liquids - Google Patents
Composition and method for stable injectable liquidsInfo
- Publication number
- AU1198601A AU1198601A AU1198601A AU1198601A AU1198601A AU 1198601 A AU1198601 A AU 1198601A AU 1198601 A AU1198601 A AU 1198601A AU 1198601 A AU1198601 A AU 1198601A AU 1198601 A AU1198601 A AU 1198601A
- Authority
- AU
- Australia
- Prior art keywords
- composition
- injectable liquids
- stable injectable
- stable
- liquids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/028244 WO2002032402A1 (en) | 2000-10-13 | 2000-10-13 | Composition and method for stable injectable liquids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1198601A true AU1198601A (en) | 2002-04-29 |
Family
ID=21741883
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001211986A Ceased AU2001211986B2 (en) | 2000-10-13 | 2000-10-13 | Composition and method for stable injectable liquids |
AU1198601A Pending AU1198601A (en) | 2000-10-13 | 2000-10-13 | Composition and method for stable injectable liquids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001211986A Ceased AU2001211986B2 (en) | 2000-10-13 | 2000-10-13 | Composition and method for stable injectable liquids |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1328255A1 (xx) |
JP (1) | JP2004513093A (xx) |
KR (1) | KR20030096224A (xx) |
CN (1) | CN100339066C (xx) |
AU (2) | AU2001211986B2 (xx) |
CA (2) | CA2424656C (xx) |
ES (1) | ES2337252T3 (xx) |
MX (1) | MXPA03003236A (xx) |
NO (1) | NO20031706L (xx) |
PL (1) | PL360052A1 (xx) |
PT (1) | PT1452171E (xx) |
WO (1) | WO2002032402A1 (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2004037293A1 (ja) * | 2002-10-22 | 2006-02-23 | 大日本住友製薬株式会社 | 安定化組成物 |
JP2007001865A (ja) * | 2003-09-16 | 2007-01-11 | Ltt Bio-Pharma Co Ltd | 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤 |
WO2005099669A1 (en) | 2004-04-13 | 2005-10-27 | Cambridge Biostability Limited | Liquids containing suspended glass particles |
GB0408199D0 (en) * | 2004-04-13 | 2004-05-19 | Cambridge Biostability Ltd | Liquids containing suspended sugar glass particles |
GB2430880A (en) * | 2005-10-04 | 2007-04-11 | Cambridge Biostability Ltd | Pharmaceutical compositions stabilized in glassy particles |
GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
US8946200B2 (en) | 2006-11-02 | 2015-02-03 | Southwest Research Institute | Pharmaceutically active nanosuspensions |
JP5301468B2 (ja) * | 2008-01-18 | 2013-09-25 | 旭化成ファーマ株式会社 | 安定な医薬組成物 |
US8404850B2 (en) | 2008-03-13 | 2013-03-26 | Southwest Research Institute | Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors |
US8722706B2 (en) | 2008-08-15 | 2014-05-13 | Southwest Research Institute | Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts |
US8309134B2 (en) | 2008-10-03 | 2012-11-13 | Southwest Research Institute | Modified calcium phosphate nanoparticle formation |
WO2010146536A1 (en) | 2009-06-18 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Suspension of particles with drug |
WO2011007327A2 (en) | 2009-07-16 | 2011-01-20 | Koninklijke Philips Electronics N.V. | Suspension for therapeutic use and device for delivering said suspension |
ES2362525B8 (es) | 2009-10-08 | 2013-01-03 | Azurebio, S.L. | Formulación de medicamentos en forma de agujas percutaneas penetrantes. |
US9028873B2 (en) | 2010-02-08 | 2015-05-12 | Southwest Research Institute | Nanoparticles for drug delivery to the central nervous system |
EP3124275A4 (en) | 2014-03-24 | 2018-03-14 | Seiko Epson Corporation | Tape printing device and tape printing system |
WO2015145353A1 (en) * | 2014-03-27 | 2015-10-01 | Novartis Ag | Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR78151B (xx) * | 1982-04-05 | 1984-09-26 | Alcon Lab Inc | |
US5518731A (en) * | 1990-09-27 | 1996-05-21 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
AU3924193A (en) * | 1992-03-19 | 1993-10-21 | Allergan, Inc. | Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid |
GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
-
2000
- 2000-10-13 CN CNB008199655A patent/CN100339066C/zh not_active Expired - Fee Related
- 2000-10-13 PL PL00360052A patent/PL360052A1/xx unknown
- 2000-10-13 CA CA2424656A patent/CA2424656C/en not_active Expired - Lifetime
- 2000-10-13 WO PCT/US2000/028244 patent/WO2002032402A1/en active IP Right Grant
- 2000-10-13 JP JP2002535640A patent/JP2004513093A/ja not_active Withdrawn
- 2000-10-13 ES ES04013422T patent/ES2337252T3/es not_active Expired - Lifetime
- 2000-10-13 CA CA2689856A patent/CA2689856C/en not_active Expired - Lifetime
- 2000-10-13 KR KR10-2003-7004941A patent/KR20030096224A/ko active Search and Examination
- 2000-10-13 EP EP00973483A patent/EP1328255A1/en not_active Withdrawn
- 2000-10-13 AU AU2001211986A patent/AU2001211986B2/en not_active Ceased
- 2000-10-13 AU AU1198601A patent/AU1198601A/xx active Pending
- 2000-10-13 PT PT04013422T patent/PT1452171E/pt unknown
- 2000-10-13 MX MXPA03003236A patent/MXPA03003236A/es active IP Right Grant
-
2003
- 2003-04-11 NO NO20031706A patent/NO20031706L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20031706D0 (no) | 2003-04-11 |
CA2424656A1 (en) | 2002-04-25 |
JP2004513093A (ja) | 2004-04-30 |
ES2337252T3 (es) | 2010-04-22 |
CN100339066C (zh) | 2007-09-26 |
EP1328255A1 (en) | 2003-07-23 |
CN1527699A (zh) | 2004-09-08 |
PL360052A1 (en) | 2004-09-06 |
MXPA03003236A (es) | 2004-12-03 |
CA2689856C (en) | 2013-09-24 |
CA2424656C (en) | 2010-03-23 |
AU2001211986B2 (en) | 2007-04-26 |
NO20031706L (no) | 2003-04-11 |
CA2689856A1 (en) | 2002-04-25 |
KR20030096224A (ko) | 2003-12-24 |
WO2002032402A1 (en) | 2002-04-25 |
PT1452171E (pt) | 2010-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5752601A (en) | Splice-region antisense composition and method | |
AU6275601A (en) | Stable polymeric micelle-type drug composition and method for the preparation thereof | |
AU6832101A (en) | Composition and method | |
GB0008264D0 (en) | Novel method and compounds | |
AU1198601A (en) | Composition and method for stable injectable liquids | |
AU4163402A (en) | Composition and method | |
HK1039883A1 (zh) | 用於穩定花色素原的組合物和方法 | |
IL148803A0 (en) | Novel composition and method for stabilizing the same | |
GB0126990D0 (en) | Method and composition for improving fuel consumption | |
HK1055071A1 (en) | New pet food composition and method | |
GB2372300B (en) | Arrangement and method for avoiding overturning | |
EP1274424A4 (en) | CONNECTIONS AND PROCEDURE | |
AU2001251083A1 (en) | Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists | |
AU4215901A (en) | Methods and compositions for immunoregulation | |
AU2001233932A1 (en) | Method and composition | |
IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
EP1451068A4 (en) | CONTAINER WITH CURVES AND METHOD OF USE | |
IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
IL145220A0 (en) | Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process | |
AU2001288107A1 (en) | Liquid deodorant composition and method for use thereof | |
EP1272512A4 (en) | IMMUNOKIN COMPOSITION AND METHOD | |
AU7220501A (en) | Mortar composition and method | |
SG88779A1 (en) | Food modification method and composition therefor | |
EP1311709A4 (en) | METHODS AND COMPOSITIONS FOR DIRECTED MOLECULAR EVOLUTION USING MODIFICATION OF THE END OF DNA | |
GB0107033D0 (en) | Method and composition |